These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 17314920

  • 1. Cannabinoids influence lipid-arachidonic acid pathways in schizophrenia.
    Smesny S, Rosburg T, Baur K, Rudolph N, Sauer H.
    Neuropsychopharmacology; 2007 Oct; 32(10):2067-73. PubMed ID: 17314920
    [Abstract] [Full Text] [Related]

  • 2. Impaired niacin sensitivity in acute first-episode but not in multi-episode schizophrenia.
    Smesny S, Rosburg T, Riemann S, Baur K, Rudolph N, Berger G, Sauer H.
    Prostaglandins Leukot Essent Fatty Acids; 2005 Jun; 72(6):393-402. PubMed ID: 15885994
    [Abstract] [Full Text] [Related]

  • 3. Endophenotype properties of niacin sensitivity as marker of impaired prostaglandin signalling in schizophrenia.
    Smesny S, Klemm S, Stockebrand M, Grunwald S, Gerhard UJ, Rosburg T, Sauer H, Blanz B.
    Prostaglandins Leukot Essent Fatty Acids; 2007 Aug; 77(2):79-85. PubMed ID: 17904833
    [Abstract] [Full Text] [Related]

  • 4. Phospholipid membrane abnormalities and reduced niacin skin flush response in schizophrenia.
    Buretić-Tomljanović A, Giacometti J, Nadalin S, Rubesa G, Vulin M, Tomljanović D.
    Psychiatr Danub; 2008 Sep; 20(3):372-83. PubMed ID: 18827766
    [Abstract] [Full Text] [Related]

  • 5. Niacin skin flush test: a research tool for studying schizophrenia.
    Nadalin S, Buretić-Tomljanović A, Rubesa G, Tomljanović D, Gudelj L.
    Psychiatr Danub; 2010 Mar; 22(1):14-27. PubMed ID: 20305586
    [Abstract] [Full Text] [Related]

  • 6. Niacin skin-flush response and electrodermal activity in patients with schizophrenia and healthy controls.
    Nilsson BM, Hultman CM, Wiesel FA.
    Prostaglandins Leukot Essent Fatty Acids; 2006 May; 74(5):339-46. PubMed ID: 16600583
    [Abstract] [Full Text] [Related]

  • 7. Relationship between the niacin skin flush response and essential fatty acids in schizophrenia.
    Messamore E.
    Prostaglandins Leukot Essent Fatty Acids; 2003 Dec; 69(6):413-9. PubMed ID: 14623495
    [Abstract] [Full Text] [Related]

  • 8. Niacin sensitivity and the arachidonic acid pathway in schizophrenia.
    Messamore E, Hoffman WF, Yao JK.
    Schizophr Res; 2010 Sep; 122(1-3):248-56. PubMed ID: 20417059
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Reduced vasodilatory response to methylnicotinate in schizophrenia as assessed by laser Doppler flowmetry.
    Ross BM, Hughes B, Turenne S, Seeman M, Warsh JJ.
    Eur Neuropsychopharmacol; 2004 May; 14(3):191-7. PubMed ID: 15056478
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prostaglandins and cannabis--VI. Release of arachidonic acid from HeLa cells by delta1-tetrahydrocannabinol and other cannabinoids.
    Burstein S, Hunter SA.
    Biochem Pharmacol; 1978 May; 27(8):1275-80. PubMed ID: 697925
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prostaglandins and cannabis XV. Comparison of enantiomeric cannabinoids in stimulating prostaglandin synthesis in fibroblasts.
    Burstein S, Hunter SA, Latham V, Mechoulam R, Melchior DL, Renzulli L, Tefft RE.
    Life Sci; 1986 Nov 10; 39(19):1813-23. PubMed ID: 3022096
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. On the relationship between methylnicotinate-induced skin flush and fatty acids levels in acute psychosis.
    Maclean R, Ward PE, Glen I, Roberts SJ, Ross BM.
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Sep 10; 27(6):927-33. PubMed ID: 14499309
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.